US Representative

Rudolph Yakym 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 7)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4035

Introduced
6/12/23  
Protecting Small Business Information Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB412

Introduced
1/20/23  
Designates the facility of the United States Postal Service located at 620 East Pecan Boulevard in McAllen, Texas, as the "Agent Raul H. Gonzalez Jr. Memorial Post Office."
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4144

Introduced
6/15/23  
FAIR Act Federal Assistance to Initiate Repayment Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4157

Introduced
6/15/23  
Refer
6/15/23  
Not Just a Number Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4167

Introduced
6/15/23  
Refer
6/15/23  
Refer
6/16/23  
Protecting America’s Distribution Transformer Supply Chain Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4175

Introduced
6/15/23  
Refer
6/15/23  
REPO for Ukrainians Act Rebuilding Economic Prosperity and Opportunity for Ukrainians Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4189

Introduced
6/15/23  
Refer
6/15/23  
CONNECT for Health Act of 2023 Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB421

Introduced
1/20/23  
Teleabortion Prevention Act of 2023 This bill restricts the use of telehealth for chemical abortions (also known as medication abortions). Specifically, it requires a provider who dispenses or prescribes medication for a chemical abortion to physically examine the patient, be physically present at the location of the chemical abortion, and schedule a follow-up visit for the patient. The bill provides an exception for a chemical abortion that is necessary to save the life of a mother whose life is endangered by a physical disorder, illness, injury, or condition. The bill establishes criminal penalties—a fine, a prison term of up to two years, or both—for a provider who does not comply with the requirements. A patient who undergoes a chemical abortion may not be prosecuted.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4227

Introduced
6/20/23  
Refer
6/20/23  
Refer
6/23/23  
ReConnecting Rural America Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB427

Introduced
1/20/23  
Refer
1/20/23  
Support And Value Expectant Moms and Babies Act of 2023 or the SAVE Moms and Babies Act of 2023 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4275

Introduced
6/22/23  
Refer
6/22/23  
Consensual Donation and Research Integrity Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB431

Introduced
1/20/23  
Life at Conception Act This bill declares that the right to life guaranteed by the Constitution is vested in each human being at all stages of life, including the moment of fertilization, cloning, or other moment at which an individual comes into being. Nothing in this bill shall be construed to authorize the prosecution of any woman for the death of her unborn child.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4323

Introduced
6/23/23  
Refer
6/23/23  
Protecting Whales, Human Safety and the Economy Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4378

Introduced
6/27/23  
Refer
6/27/23  
SMART Energy Efficiency Standards Act Strengthening Manufactured Appliance Requirements towards Thoughtful Energy Efficiency Standards Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB451

Introduced
1/24/23  
Protecting Families from Fertility Fraud Act of 2023 This bill establishes a new federal criminal offense for knowingly misrepresenting the nature or source of DNA used in assisted reproductive technology or assisted insemination. The term assisted reproductive technology includes any treatment or procedure that involves the handling of human oocytes or embryos, such as in vitro fertilization, gamete intrafallopian transfer, and zygote intrafallopian transfer. The term assisted insemination includes any procedure that involves the handling of sperm including intrauterine insemination. A violation is subject to a fine, a prison term of up to 10 years, or both. Additionally, the bill makes the violation a predicate offense (i.e., an underlying offense) for prosecutions under the federal racketeering statute.